The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20070357: BlackRock Kelso Capital Holding LLC; Joseph A. Megy
20070340: 3M Company; Don Segal
20070332: Rhone Capital L.L.C.; Compar Invest S.A.
20061437: Johnson & Johnson; Pfizer Inc.
Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules
20070418: Motorola, Inc.; Good Technology, Inc.
20070356: Nidec Corporation; Valeo S.A.
20070351: AEGON, N.V.; Clark, Inc.
0612006 Informal Interpretation
0602005 Informal Interpretation
Barr Pharmaceuticals, Inc., In the Matter of
The consent order settles charges that Barr Pharmaceutical, Inc.’s proposed acquisition of Pliva d.d for approximately $2.5 billion would have eliminated current or future competition between Barr and Pliva in certain markets for generic pharmaceuticals treating depression, high blood pressure and ruptured blood vessels, and in the market for organ preservation solutions. In settling the Commission’s charges, Barr is required to sell its generic antidepressant trazodone and its generic blood pressure medication triamterene/HCTZ. Barr also is required to divest either Pliva’s or Barr’s generic nimodipine for use in treating ruptured blood vessels in the brain. Finally, Barr is required to divest Pliva’s branded organ preservation solution Custodial.